Selective Norepinephrine RU Inhibitors (Sel-NARI)

The phrase "Selective Norepinephrine RU Inhibitors (Sel-NARI)" is an administrative or formulary classification abbreviation—where "RU" denotes "reuptake"—rather than a standard standalone clinical nomenclature

The phrase "Selective Norepinephrine RU Inhibitors (Sel-NARI)" is an administrative or formulary classification abbreviation—where "RU" denotes "reuptake"—rather than a standard standalone clinical nomenclature

The phrase "Selective Norepinephrine RU Inhibitors (Sel-NARI)" is an administrative or formulary classification abbreviation—where "RU" denotes "reuptake"—rather than a standard standalone clinical nomenclature Clinically recognized as selective norepinephrine (or noradrenaline) reuptake inhibitors (sNRIs or NARIs), these agents selectively inhibit the presynaptic norepinephrine transporter (NET) to prevent the reuptake of norepinephrine and prolong noradrenergic neurotransmission in the central...

Clinically recognized as selective norepinephrine (or noradrenaline) reuptake inhibitors (sNRIs or NARIs), these agents selectively inhibit the presynaptic norepinephrine transporter (NET) to prevent the reuptake of norepinephrine and prolong noradrenergic neurotransmission in the central nervous system They are primarily utilized in the management of attention-deficit/hyperactivity disorder (ADHD), with representative agents such as atomoxetine and viloxazine, as well as in major depressive dis...

Clinically recognized as selective norepinephrine (or noradrenaline) reuptake inhibitors (sNRIs or NARIs), these agents selectively inhibit the presynaptic norepinephrine transporter (NET) to prevent the reuptake of norepinephrine and prolong noradrenergic neurotransmission in the central nervous system They are primarily utilized in the management of attention-deficit/hyperactivity disorder (ADHD), with representative agents such as atomoxetine and viloxazine, as well as in major depressive dis...